Another university hairloss product..
Lets wait.......
http://www.yonhapnews.co.kr/bulletin/2017/11/20/0200000000AKR20171120080600017.HTML
They mention full regrowth. ...
Based on this finding, the researchers have developed a biochemical substance, PTD-DBM, that prevents CXXC from binding with the Dishevelled protein. When the substance was applied on the bare skin of laboratory mice, they saw new hair follicle growth.
Five more years (tm) unless we can figure out how to have it made independently or purchase it for research and test it ourselves.by 2023 if it sails through phases 1-3 similarly.
“Disrupting the CXXC5-Dishevelled interaction with a competitor peptide activated the Wnt/β-catenin pathway and accelerated hair regrowth and wound-induced hair follicle neogenesis,” the paper said.
The entire mouse study system is flawed. If we keep studying mice we're going to cure every possible mouse disease, but 80% of drugs that work in mice don't work in humans. How many that don't work in mice would work in humans? We need to study humans if we want to find human cures, but that's never going to happen. So we have to make-do with our furry friends and hope that eventually we run into something that works on both mice and humans.
The entire mouse study system is flawed. If we keep studying mice we're going to cure every possible mouse disease, but 80% of drugs that work in mice don't work in humans. How many that don't work in mice would work in humans? We need to study humans if we want to find human cures, but that's never going to happen. So we have to make-do with our furry friends and hope that eventually we run into something that works on both mice and humans.
This is called pre-clinical and Phase I studies. It's not flawed, this is the procedure.
Phase II and III are for humans. If it doesn't work on mice, it won't on humans. Then you can add chimp and pigs.
Then,test it on humans.
Phase IV is post-commercialisation.
And to your 80% I don't know where you've got this, but all studies and researchs are done like this.
And yes this is never going to happen because it's called safety I prefer to be alive and have the chance to see a cure than dyin' bald because they didn't test it on animals previously.
The problem is not mice, the problems is the time they need to get approval from FDA and other agencies.
the problem is that companies need a working product first tbh, and not just a hype balloon for attracting investors.
why ignore the elephant in the room
The problem is not the hype. The proble here is SAFETY. Safety first, effectiveness after.
You don't drive a car without belts/airbag in aren't you?
almost all of those failed treatments easily pass the safety test, but when effectiveness needs to be demonstrated, all kinds of complications magically arise. come up with a working solution and you ll cruise through trials and nobody will have a problem waiting for a couple of years to get it.
"administration" problem exists, but its also conveniently used as an excuse. system of financing (and the financial issue itself) of those startups and public institute research is where the problem lies, imho. makes it more important to know how to advertise and hype a POTENTIAL treatment up than to be advanced in actual science.
is FDA regulation the reason Follica is still mumbling about "hoping to start the initiation of the organisation of the optimization study for their pivotal trial" in late 2017? of course not.
B
Bro testing on humans before animals is trying to run before learning to crawl.
The protocol is slow, but the order makes sense. Don't forget that there are innocent human lives ar stake, also.
almost all of those failed treatments easily pass the safety test, but when effectiveness needs to be demonstrated, all kinds of complications magically arise. come up with a working solution and you ll cruise through trials and nobody will have a problem waiting for a couple of years to get it.
"administration" problem exists, but its also conveniently used as an excuse. system of financing (and the financial issue itself) of those startups and public institute research is where the problem lies, imho. makes it more important to know how to advertise and hype a POTENTIAL treatment up than to be advanced in actual science.
is FDA regulation the reason Follica is still mumbling about "hoping to start the initiation of the organisation of the optimization study for their pivotal trial" in late 2017? of course not.